INVEX Therapeutics Ltd (IXC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.171x

Based on the latest financial reports, INVEX Therapeutics Ltd (IXC) has a cash flow conversion efficiency ratio of -0.171x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-779.73K ≈ $-551.71K USD) by net assets (AU$4.55 Million ≈ $3.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See INVEX Therapeutics Ltd (IXC) defensive interval to measure how many days the company can operate on defensive assets alone.

INVEX Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how INVEX Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

INVEX Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INVEX Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Compagnie des Eaux de Royan PA:MLEDR	N/A
Cohort LSE:CHRT	-0.188x
NB Private Equity Partners Ltd LSE:NBPE	0.101x
HYPERCHARGE NETWORKS CORP F:PB7	-0.296x
Future Consumer Limited NSE:FCONSUMER	-0.022x
Careteq Ltd AU:CTQ	-0.265x
Enthusiast Gaming Holdings Inc TO:EGLX	1.951x
Upsellon Brands Holdings Ltd TA:UPSL	-0.117x

Annual Cash Flow Conversion Efficiency for INVEX Therapeutics Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of INVEX Therapeutics Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see how much is INVEX Therapeutics Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$5.25 Million ≈ $3.71 Million	AU$-652.57K ≈ $-461.74K	-0.124x	+71.05%
2024-06-30	AU$5.69 Million ≈ $4.02 Million	AU$-2.44 Million ≈ $-1.73 Million	-0.430x	-32.80%
2023-06-30	AU$21.23 Million ≈ $15.02 Million	AU$-6.87 Million ≈ $-4.86 Million	-0.324x	-172.89%
2022-06-30	AU$28.48 Million ≈ $20.15 Million	AU$-3.38 Million ≈ $-2.39 Million	-0.119x	-126.62%
2021-06-30	AU$32.08 Million ≈ $22.70 Million	AU$-1.68 Million ≈ $-1.19 Million	-0.052x	+20.38%
2020-06-30	AU$24.40 Million ≈ $17.27 Million	AU$-1.60 Million ≈ $-1.13 Million	-0.066x	-226.59%
2019-06-30	AU$11.44 Million ≈ $8.09 Million	AU$-230.13K ≈ $-162.83K	-0.020x	--

About INVEX Therapeutics Ltd

AU:IXC Australia Biotechnology

Market Cap

$6.91 Million

AU$9.77 Million AUD

Market Cap Rank

#27885 Global

#1443 in Australia

Share Price

AU$0.13

Change (1 day)

+0.00%

52-Week Range

AU$0.08 - AU$0.16

All Time High

AU$1.67